The efficacy of nonestrogenic therapy to hot flashes in cancer patients under hormone manipulation therapy: A systematic review and meta-analysis

Journal of Cancer Research and Clinical Oncology

Volumn 139, Issue 10, 2013, Pages 1701-1707

  Yamaguchi, N ^a   Okajima, Y ^b,c   Fujii, T ^c   Natori, A ^c   Kobayashi, D ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

Author keywords

Breast cancer; Gabapentin; Hormone; Hot flashes; Prostate cancer; Venlafaxine

Indexed keywords

ALPHA TOCOPHEROL; CLONIDINE; GABAPENTIN; PLACEBO; VENLAFAXINE;

ARTICLE; CANCER HORMONE THERAPY; CANCER PATIENT; DRUG EFFICACY; HOT FLUSH; HUMAN; META ANALYSIS; NONESTROGENIC THERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; THERAPY;

AMINES; ANTINEOPLASTIC AGENTS, HORMONAL; CYCLOHEXANECARBOXYLIC ACIDS; CYCLOHEXANOLS; GAMMA-AMINOBUTYRIC ACID; HOT FLASHES; HUMANS; NEOPLASMS, HORMONE-DEPENDENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84884672293     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-013-1491-4     Document Type: Article

References (28)

1. Atkins D, Best D, Briss PA et al (2004) Grading quality of evidence and strength of recommendations. BMJ 328(7454):1490
2. Biglia N, Torta R, Roagna R et al (2005) Evaluation of low-dose venlafaxine hydrochloride for the therapy of hot flushes in breast cancer survivors. Maturitas 52(1):78-85
3. Biglia N, Sgandurra P, Peano E et al (2009) Non-hormonal treatment of hot flushes in breast cancer survivors: gabapentin vs. vitamin E. Climacteric 12(4):310-318
4. Boekhout AH, Vincent AD, Dalesio OB et al (2011) Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial. J Clin Oncol 29(29):3862-3868
5. Bordeleau L, Pritchard KI, Loprinzi CL et al (2010) Venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors. J Clin Oncol 28(35):5147-5152
6. Buijs C, Mom CH, Willemse PH et al (2009) Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study. Breast Cancer Res Treat 115(3):573-580
7. Carpenter JS, Andrykowski MA, Cordova M et al (1998) Hot flashes in postmenopausal women treated for breast carcinoma: prevalence, severity, correlates, management, and relation to quality of life. Cancer 82(9):1682-1691
8. Carpenter JS, Storniolo AM, Johns S et al (2007) Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer. Oncologist 12(1):124-135
9. Charig CR, Rundle JS (1989) Flushing long-term side effect of orchiectomy in treatment of prostatic carcinoma. Urology 33(3):175-178
10. Chlebowski RT, Kuller LH, Prentice RL et al (2009) Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med 360(6):573-587
11. Couzi RJ, Helzisouer KJ, Fetting JH (1995) Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. J Clin Oncol 13(11):2737-2744
12. Furukawa TA, Barbui C, Cipriani A et al (2006) Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol 59(1):7-10
13. Hershman DL, Shao T, Kushi LH et al (2011) Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat 126(2):529-537
14. Higgins JP, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557-560
15. Ioannidis JP, Trikalinos TA (2007) The appropriateness of asymmetry tests for publication bias in meta-analysis: a large study. CMAJ 176(8):1091-1096
16. Irani J, Salomon L, Oba R et al (2010) Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial. Lancet Oncol 11(2):147-154
17. Loibi S, Schwedler K, von Minckwitz G et al (2007) Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients-a double-blind, randomized study. Ann Oncol 18(4):689-693
18. Loprinzi CL, Kugler JW, Sloan JA et al (2000) Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 356(9247):2059-2063
19. Loprinzi CL, Dueck AC, Khoyratty BS et al (2009) A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB). Ann Oncol 20(3):542-549
20. McCowan C, Shearer J, Donnan PT et al (2008) Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer. Br J Cancer 99(11):1763-1768
21. Moher D, Liberati A, Tetzlaff J et al (2009) PRISMA Group.preferred reporting items for systematic reviews and meta-analyses: the prisma statement. PLoS Med 6(7):e1000097
22. Pandya KJ, Morrow GR, Roscoe JA et al (2005) Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet 366(9488):818-824
23. Rada G, Capurro D, Pantoja T et al (2010) Non-hormonal interventions for hot flashes in women with a history of breast cancer. Cochrane Database Syst Rev 8(9):CD004923
24. Rhoden EL, Averbeck MA, Teloken PE (2008) Androgen replacement in men undergoing treatment for prostate cancer. J Sex Med 5(9):2202-2208
25. Savard MH, Savard J, Quesnel C et al (2009) The influence of breast cancer treatment on the occurrence of hot flashes. J Pain Symptom Manage 37(4):687-697
26. Siegel R, Desantis C, Virgo K et al. (2012) Cancer treatment and survivorship statistics CA Cancer J Clin 2012 Published on June 14 2012 doi: 10.3322/caac.21149
27. Sloan JA, Loprinzi CL, Novotny PJ et al (2001) Methodologic lessons learned from hot flash studies. J Clin Oncol 19(23):4280-4290
28. Walker EM, Rodriguez AI, Kohn B et al (2010) Acupuncture versus venlafaxine for the management of vasomotor symptoms in patients with hormone receptor-positive breast cancer: a randomized controlled trial. J Clin Oncol 28(4):634-640